Apuli Maricel — SEC Form 4 filings
SEC reporting owner CIK 2058197. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2025-03-21 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 10,536 shares, $706,647 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 2,000 shares @ $80.06 ($160,120) in BridgeBio Pharma, Inc., filed 2026-08-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Chief Accounting Officer | 15 | — | 7 legs · 10,536 sh · $706,647 | 9 |
Form 4 filings — Apuli Maricel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,714 @ $79.86 | EDGAR |
| 2026-08-03 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,000 @ $80.06 | EDGAR |
| 2026-05-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,714 @ $66.13 | EDGAR |
| 2026-05-04 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,000 @ $71.58 | EDGAR |
| 2026-03-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 14,170 @ $0 | EDGAR |
| 2026-02-27 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,000 @ $66 | EDGAR |
| 2026-02-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,349 @ $75.25 · Sale (S): 510 @ $74.31 | EDGAR |
| 2025-12-16 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 2,003 @ $75.15 | EDGAR |
| 2025-12-10 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 2,000 @ $74.26 | EDGAR |
| 2025-11-18 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,781 @ $66.39 | EDGAR |
| 2025-08-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,781 @ $51.32 | EDGAR |
| 2025-08-11 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 1,000 @ $45.44 | EDGAR |
| 2025-05-20 | 4 | BridgeBio Pharma, Inc. (BBIO) | Tax withholding (F): 4,780 @ $33.84 | EDGAR |
| 2025-05-06 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 1,026 @ $38.51 | EDGAR |
| 2025-03-21 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 23,660 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2058197 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →